New hope for teens with fragile x: drug trial targets learning and behavior
Disease control
Completed
This study tested an investigational drug, BPN14770, to see if it could improve thinking skills, language, and daily functioning in male adolescents with Fragile X Syndrome. It involved 163 boys aged 9 to 18 and compared the drug's effects to a placebo over 13 weeks. The main goa…
Phase: PHASE2, PHASE3 • Sponsor: Tetra Discovery Partners • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC